Nick Staples

Nick Staples Email and Phone Number

Nick Staples's Location
London, England, United Kingdom, United Kingdom
Nick Staples's Contact Details

Nick Staples personal email

n/a
About Nick Staples

A former senior exec in the Biotech industry with more than 20 years international experience in corporate and business development. Previous roles include CEO at Avvinity Therapeutics and Locate Bio and CBO roles at Artios Pharma and TopiVert Pharma, as well as senior positions in a number of public companies including Protherics plc, Vectura plc and SSL International plc. Nick was a critical player in the completion of several major private and public fund raises, M&A, licensing, new business ventures and other transactions in UK, US, Australia, China and Brazil.

Nick Staples's Current Company Details
AMBERJACK CONSULTING LIMITED

Amberjack Consulting Limited

View
Retired
Nick Staples Work Experience Details
  • Amberjack Consulting Limited
    Corporate And Business Development
    Amberjack Consulting Limited Nov 2013 - Present
    London, United Kingdom
    Various business development and corporate development projects for clients including: (i) the acquisition for Abzena PLC of PacificGMP, a privately held contract biopharmaceutical development and manufacturing company (CDMO) based in San Diego, CA, USA (ii) corporate development role for Retroscreen plc which included a £4 million all share acquisition of Activiomics Ltd a private UK proteomics company, a successful £33.6 million fundraising and a corporate rebranding in line with the company's broader business strategy.(iii) a range of other corporate development projects including due diligence, valuation and transaction support.
  • Avvinity Therapeutics Limited
    Chief Executive Officer
    Avvinity Therapeutics Limited Nov 2020 - Oct 2022
    London, England, United Kingdom
    CEO of Avvinity Therapeutics, an early stage, UK based, immuno-oncology company developing Alphamer® immunotherapies for solid and haematological cancers. Avvinity's proprietary Alphamer technology directs pre-existing polyclonal anti-sugar antibodies to tumour cells, thereby triggering a powerful immune response (innate and adaptive) which eradicates the target cells in a highly selective manner.
  • Locate Bio Ltd
    Chief Executive Officer
    Locate Bio Ltd Nov 2018 - May 2020
    Nottingham
    Locate Bio is a private UK regenerative medicine company developing next generation technologies to overcome the current limitations in cell therapy and gene therapy approaches. The company is progressing a pipeline of novel regenerative medicines in high value orthopaedic indications and evaluating additional opportunities in other diseases where cell and gene therapies may deliver breakthrough and potentially curative benefits to patients.
  • Artios Pharma Ltd
    Chief Business Officer
    Artios Pharma Ltd Sep 2016 - Oct 2018
    Cambridge, United Kingdom
    Artios is a new DNA Damage Response (DDR) company focussed on developing first-in-class treatments for cancer. Nick was involved in the set up and seed financing of the company, in addition to establishing a research collaboration with, and the in-licensing of two lead DDR programmes from, Cancer Research Technology (CRT) together with the completion of a £25.0 million ($33.2 million) Series A fundraise.
  • Topivert Pharma Ltd
    Chief Business Officer
    Topivert Pharma Ltd Aug 2016 - Oct 2018
    London, United Kingdom
  • Vectura
    Director Of Business Development & Licensing, Emerging Markets
    Vectura Nov 2012 - Sep 2013
    Interim role focused on business development and licensing activities to leverage in-house respiratory products and technologies in key emerging markets including China
  • Vectura
    Director Of Corporate Development, Emerging Markets
    Vectura Jan 2011 - Nov 2012
    Lead role in establishing a Chinese JV company called Tianjin Kinnovata Pharmaceutical Company Limited in China with two partners: Tianjin KingYork Pharmaceuticals Tianjin KingYork Group Company Limited ("KingYork"), a leading Chinese pharmaceutical company and specialist manufacturer of corticosteroid based products, and Zendex Bio Strategy Inc a private equity investor based in Hong Kong.Kinnovata will develop, manufacture and commercialise respiratory products for the rapidly growing domestic Chinese and other regional markets in Asia.
  • Ssl International
    Director Of Business Development
    Ssl International Apr 2010 - Jan 2011
    Primarily focused on growing global brands Durex and Scholl through international product acquisitions prior to SSL's acquisition by Reckitt Benckiser
  • Njs Consulting
    Founder
    Njs Consulting Apr 2009 - Mar 2010
    Freelance business development consulting for a number of international clients
  • Protherics
    Director Of Corporate Affairs (Corporate Development)
    Protherics Nov 2003 - Apr 2009
    London, United Kingdom
    A broad corporate development role, reporting into CEO, responsible for corporate strategy, M&A, IR/PR, fundraising and managing the capital markets
  • Westlb Panmure
    Equity Analyst
    Westlb Panmure Oct 2000 - Jul 2003
    London, United Kingdom
    A prominent and respected analyst in the leading biotech banking franchise in the EU at the time. Lead analyst on eight Life Science companies in the EU, generating significant secondary commission as the authoritative voice on several high profile stocks
  • Pa Consulting Group
    Consultant
    Pa Consulting Group 1997 - 2000
    Management Consultant in the Life Sciences Team within the Technology Consulting Practice. Primary focus was on due diligence for IPOs and M&A, product forecasting including 9 months secondment tor GSK, and the strategic implications of biotechnology on existing industries.

Nick Staples Skills

Strategy Biotechnology Due Diligence Pharmaceutical Industry Business Strategy Corporate Development Mergers And Acquisitions Business Development Life Sciences Business Planning Technology Transfer Lifesciences Mergers Licensing Management Emerging Markets Valuation New Business Development Equities Financial Modeling Strategic Planning Drug Development Biopharmaceuticals Management Consulting Financial Analysis Fundraising Pharmaceuticals Healthcare Negotiation Strategy Development Competitive Analysis Market Analysis

Nick Staples Education Details

Frequently Asked Questions about Nick Staples

What company does Nick Staples work for?

Nick Staples works for Amberjack Consulting Limited

What is Nick Staples's role at the current company?

Nick Staples's current role is Retired.

What is Nick Staples's email address?

Nick Staples's email address is nj****@****ail.com

What schools did Nick Staples attend?

Nick Staples attended University Of Cambridge, University Of Leeds.

What skills is Nick Staples known for?

Nick Staples has skills like Strategy, Biotechnology, Due Diligence, Pharmaceutical Industry, Business Strategy, Corporate Development, Mergers And Acquisitions, Business Development, Life Sciences, Business Planning, Technology Transfer, Lifesciences.

Not the Nick Staples you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.